Healthcare provider profile · identity verified

Jonathan Winter, MD

Family Practice · FRONT ROYAL, VA · NPI 1316129976

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	217	69
Gabapentin	Gabapentin	191	40
Prednisone	Prednisone	168	59
Amlodipine Besylate	Amlodipine Besylate	141	43
Levothyroxine Sodium	Levothyroxine Sodium	138	35
Losartan Potassium	Losartan Potassium	125	40
Omeprazole	Omeprazole	125	36
Rosuvastatin Calcium	Rosuvastatin Calcium	122	44
Lisinopril	Lisinopril	121	39
Metoprolol Succinate	Metoprolol Succinate	118	37
Trazodone Hcl	Trazodone Hcl	117	29
Duloxetine Hcl	Duloxetine Hcl	106	28
Pantoprazole Sodium	Pantoprazole Sodium	106	34
Tamsulosin Hcl	Tamsulosin Hcl	99	31
Metformin Hcl Er	Metformin Hcl	97	26
Albuterol Sulfate Hfa	Albuterol Sulfate	96	39
Sertraline Hcl	Sertraline Hcl	95	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	15
Mounjaro	Tirzepatide	92	16
Alprazolam	Alprazolam	88	21
Clonazepam	Clonazepam	82	12
Eliquis	Apixaban	81	25
Oxycodone Hcl	Oxycodone Hcl	79	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	15
Furosemide	Furosemide	76	28
Potassium Chloride	Potassium Chloride	74	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	15
Famotidine	Famotidine	56	16
Meloxicam	Meloxicam	54	20
Metformin Hcl	Metformin Hcl	54	19
Jardiance	Empagliflozin	52	17
Pregabalin	Pregabalin	51	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	15
Bupropion Xl	Bupropion Hcl	47	13
Simvastatin	Simvastatin	47	14
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	suppressed
Breo Ellipta	Fluticasone/Vilanterol	44	suppressed
Azithromycin	Azithromycin	41	27
Doxycycline Hyclate	Doxycycline Hyclate	41	27
Hydrochlorothiazide	Hydrochlorothiazide	40	17
Mirtazapine	Mirtazapine	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	11
Metoprolol Tartrate	Metoprolol Tartrate	37	13
Allopurinol	Allopurinol	36	13
Donepezil Hcl	Donepezil Hcl	36	suppressed
Fluconazole	Fluconazole	36	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Lorazepam	Lorazepam	36	suppressed
Spironolactone	Spironolactone	35	11
Topiramate	Topiramate	35	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Finasteride	Finasteride	32	suppressed
Nystatin	Nystatin	32	18
Diclofenac Sodium	Diclofenac Sodium	31	16
Montelukast Sodium	Montelukast Sodium	30	13
Vitamin D2	Ergocalciferol (Vitamin D2)	30	13
Fluticasone Propionate	Fluticasone Propionate	28	17
Levofloxacin	Levofloxacin	28	16
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	11
Buspirone Hcl	Buspirone Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Carvedilol	Carvedilol	26	11
Fentanyl	Fentanyl	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Xolair	Omalizumab	26	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Methadone Hcl	Methadone Hcl	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Cephalexin	Cephalexin	16	14
Fluocinonide-E	Fluocinonide/Emollient Base	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Divalproex Sodium	Divalproex Sodium	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Atenolol	Atenolol	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Valsartan	Valsartan	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Ozempic	Semaglutide	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Cefdinir	Cefdinir	11	11
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error